[
    [
        {
            "time": "2018-01-03",
            "original_text": "Strong, Diverse Dividend Stocks to Buy with Market at New Highs",
            "features": {
                "keywords": [
                    "strong",
                    "dividend",
                    "stocks",
                    "market",
                    "new highs"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Strong, Diverse Dividend Stocks to Buy with Market at New Highs",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-04",
            "original_text": "FDA Denies Approval for Gilead Sciences' Potential Blockbuster Arthritis Drug",
            "features": {
                "keywords": [
                    "FDA",
                    "denies",
                    "approval",
                    "Gilead",
                    "blockbuster",
                    "arthritis",
                    "drug"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "FDA Denies Approval for Gilead Sciences' Potential Blockbuster Arthritis Drug",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-05",
            "original_text": "Potential Gilead Blockbusters Were Rejected By the FDA. Why That’s the ‘Near-Worst-Case Scenario’ for the Stock.",
            "features": {
                "keywords": [
                    "potential",
                    "Gilead",
                    "blockbusters",
                    "rejected",
                    "FDA",
                    "near-worst-case",
                    "scenario",
                    "stock"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Potential Gilead Blockbusters Were Rejected By the FDA. Why That’s the ‘Near-Worst-Case Scenario’ for the Stock.",
                "Correlation": 10,
                "Sentiment": 1,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-06",
            "original_text": "Dow Jones Today, Stocks Mixed; Target Heads Retail Rally; Biotechs Momenta, Gilead, BioMarin Swing Wild On Merger, FDA News",
            "features": {
                "keywords": [
                    "Dow",
                    "Jones",
                    "stocks",
                    "mixed",
                    "Target",
                    "retail",
                    "rally",
                    "biotechs",
                    "Momenta",
                    "Gilead",
                    "BioMarin",
                    "swing",
                    "wild",
                    "merger",
                    "FDA",
                    "news"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "retail"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "Dow Jones Today, Stocks Mixed; Target Heads Retail Rally; Biotechs Momenta, Gilead, BioMarin Swing Wild On Merger, FDA News",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-07",
            "original_text": "Dow Jones Today, Stocks Open On This Rise; Target Heads Retail Rally; Biotechs Momenta, Gilead, Biomarin Swing Wild On Merger, FDA News",
            "features": {
                "keywords": [
                    "Dow",
                    "Jones",
                    "stocks",
                    "open",
                    "rise",
                    "Target",
                    "retail",
                    "rally",
                    "biotechs",
                    "Momenta",
                    "Gilead",
                    "Biomarin",
                    "swing",
                    "wild",
                    "merger",
                    "FDA",
                    "news"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "retail"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dow Jones Today, Stocks Open On This Rise; Target Heads Retail Rally; Biotechs Momenta, Gilead, Biomarin Swing Wild On Merger, FDA News",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-08",
            "original_text": "Dow Jones Today, Futures Mixed; Target Heads Retail Rally; Gilead, Biomarin Swoon As FDA Balks",
            "features": {
                "keywords": [
                    "Dow",
                    "Jones",
                    "futures",
                    "mixed",
                    "Target",
                    "retail",
                    "rally",
                    "Gilead",
                    "Biomarin",
                    "swoon",
                    "FDA",
                    "balks"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "retail"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Dow Jones Today, Futures Mixed; Target Heads Retail Rally; Gilead, Biomarin Swoon As FDA Balks",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]